SUBSCRIBE
SUBSCRIBE
News   Policy

US FDA Staff Against Wider Approval of Forest Laboratories, Inc. (JOBS) Drug

January 7, 2010 | 
1 min read

Bookmark and Share

Reuters -- A Forest Laboratories Inc hypertension drug should not be approved for people with heart failure, a U.S. drug reviewer said in a preliminary analysis released on Thursday.

Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Podcasts
COVID Reflections, Novo’s Next-Gen Weight Loss Struggles, Another Depression Miss, More
March 12, 2025
 · 
1 min read
 · 
Heather McKenzie
Close-Up Of Medicine Bottles Against Green Background
Opinion
FDA Faces Challenging Decision on Biomarker-Based Label Restrictions
March 10, 2025
 · 
5 min read
 · 
Harpreet Singh
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: GSK, Alnylam, Sanofi and More
March 10, 2025
 · 
7 min read
 · 
Tristan Manalac
Editorial
FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go
March 7, 2025
 · 
3 min read
 · 
Jef Akst